Xuejun Zheng
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CD4+ T cell count mediates the association between gut microbiota and diabetic kidney disease progression.
Journal: Frontiers in cellular and infection microbiology
Published: September 05, 2025
Glycosylation-Related Genes and Prognostic Signatures in Diabetic Nephropathy.
Journal: International journal of general medicine
Published: June 07, 2025
FG-4592 relieves diabetic kidney disease severity by influencing metabolic profiles via gut microbiota reconstruction in both human and mouse models.
Journal: Frontiers in physiology
Published: March 28, 2023
Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.
Journal: Frontiers in pharmacology
Published: October 19, 2022
The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome-metabolome combined validation in a mouse model.
Journal: Frontiers in endocrinology
Published: June 08, 2022
Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 18, 2022
SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway.
Journal: Frontiers in pharmacology
Published: March 15, 2022
Behavioral Assessment of Sensory, Motor, Emotion, and Cognition in Rodent Models of Intracerebral Hemorrhage.
Journal: Frontiers in neurology
Published: February 15, 2021
Gut microbiota, key to unlocking the door of diabetic kidney disease.
Journal: Nephrology (Carlton, Vic.)
Published: January 05, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026